Prophylaxis of acute upper gastrointestinal bleeding by control of gastric pH has been widely advocated for intensive care patients. H[blockers and antacids have been used and demonstrated to be incompletely effective at maintaining gastric pH above 4. A study of 100 patients measured the efficacy of two-hourly gastric pH measurement and titrated therapy consisting of jive levels: I. no therapy 2. ranitidine 50 mg 8 hourly intravenously 3. ranitidine plus Mylanta 30 ml 2 hourly by nasogastric tube 4. ranitidine plus Mylanta 60 ml 2 hourly and 5. ranitidine 100 mg 8 hourly intravenously plus Mylanta Il 60 ml 2 hourly. The level of treatment required by proportions of the total study group were (J) 15%, (2) 71%, (3) 96%, (4) 100%. Head-injured and intubated patients generally fell in the more resistant group while patients having had major elective surgery required lower levels of therapy. If control of gastric pH is to be uniformly achieved, a technique of titrated therapy based on gastric pH measurements is supported as cheaper and more effective than other standardised treatment regimens.
It is now widely recognised that there has been a decrease in the incidence of overt significant haemorrhage from gastric stress ulcers among the critically ill. 1,2 It has been suggested that alkalisation prophylaxis plus improved respiratory support, resuscitation, control of sepsis, nutrition and renal support have been responsible for this decrease. 1, 3 Before the development of prophylactic regimens, haemorrhage associated with gastric stress ulceration was described as a common complication of critical illness, with high mortality. 4, 5 Subsequent advances in the understanding of the pathophysiology of gastric stress ulceration and an appreciation of the importance of avoiding or limiting gastric mucosal insults lead to the development of measures of prophylaxis. 3 ,6-9 Prophylaxis was based on the belief that gastric acid contributed to the development of gastric ulceration. By elevating the gastric pH, stress ulceration and subsequent significant haemorrhage from the ulceration could be reduced, The period of pH control necessary and the optimum level of pH remain unknown, However, a gastric pH level of greater than 3.5 has been used as a clinical endpoint of therapy.
Alkalisation of the gastric contents is now one of the routine and effective methods of prophylaxis against stress ulcer bleeding. Alkalisation prophylaxis has been subjected to numerous studies assessing the issues of prophylaxis regimen II and comparison of the methods of prophylaxis. 12 - 15 These studies have been subjected to review and comment. 3 ,10,16-19 These reviews support the view that alkalisation is safe and effective in reducing the incidence of overt gastric haemorrhage from stress ulceration in the critically ill and that both antacid and Hrantagonist agents (ranitidine and cimetidine) are effective. 16,18 Titrated antacids have been shown to be more efficient than H 2antagonists in maintaining a target set of pH control. 16 However, it has been suggested that Hr antagonists are equally effective as a measure of prophylaxis despite the lack of twenty-four hour control of pH. 20 A third approach to prophylaxis uses the knowledge that patient groups at increased risk of gastric stress ulceration such as sepsis, trauma and multisystem organ failure can be identified, thus making it possible to target the use of prophylaxis. 2 ,3,11 It has been suggested that while a regimen of Hrantagonist may be effective in the majority of patients, the addition of antacid and its titration to a pH end-point may be desirable in selected high risk patients. 2o This study was undertaken with three goals in mind: 1. to determine the proportion of patients requiring the various levels of therapy and whether in fact there is an identifiable subset of patients who need no therapy at all; 2. to look at predictors of resistance to therapy; 3. to determine the usefulness of a titrated approach for therapy to pH end point, rather than a standardised treatment regimen, in a general intensive care population.
METHODS
The study was conducted in a nine-bed, teaching hospital general intensive care unit over the period August 1988 to May 1989. The unit admitted 446 patients during that time including 266 (60%) for elective postoperative care and 180 (40%) for other reasons. Patients were entered into the study if they had in place a nasogastric tube capable of aspiration and were not receiving any enteral nutrition. The standard practice for prophylaxis of gastrointestinal bleeding was to monitor the pH of gastric aspirate second hourly and utilise graded therapy of Ranitidine (Glaxo) and Mylanta 11 (Park Davis) to maintain the pH greater than 4. The five levels of treatment used were: 1. no therapy; 2. ranitidine 50 mg 8 hourly intravenously; 3. ranitidine plus mylanta 30 ml 2 hourly by nasogastric tube; 4. ranitidine plus mylanta 60 ml 2 hourly by nasogastric tube; 5. ranitidine 100 mg 8 hourly IV plus mylanta 60 ml 2 hourly by nasogastric tube.
If renal failure was present the dose of ranitidine was reduced according to the manufacturer's recommendations.
Gastric pH was assessed by applying a drop of gastric aspirate to reagent test strips (Merck Universal pH indicator 0-14 available from FFE Pty. Ltd. Sydney).
Two successive readings of pH < 4 were required before therapy was increased a level. Once therapy was effective in maintaining pH> 4 it was left unchanged for the remainder of the patient's stay or until enteral feeding was commenced. The decision to utilise alternative treatments instead ofthe unit's standard therapy remained at the discretion ofthe patient's treating physicians. This discretion was not in fact exercised during the study.
An initial sample size of one hundred successive, eligible patients was selected arbitrarily. On analysis of the first hundred cases, four were found to have incomplete data sets. The collection of further data to improve statistical power of the study was considered unwarranted. To improve the power with respect to some less frequently encountered groups, further investigations are required.
Information was recorded about each patient's demographic data and risk factors and a record was kept of the pH measurements and therapy administered during his or her stay.
Demographic data included age and gender while the following risk factors were assessed clinically. Positive past history: History of upper gastrointestinal ulceration or haemorrhage prior to arrival in ICU. Non-steroidal anti inflammatory drugs (NSAI) or steroid use: During current hospital admission. Sepsis: Based on clinical and blood culture evidence.
Head injury: Acutely related to this hospital admission.
Multiple trauma: Significant injury to more than one body part on this admission. Burn: Bum injury of > 20% body surface or involving respiratory tract. Respiratory failure: Hypoxaemia or hypercarbia requiring intervention beyond the use of supplemental oxygen by face mask. Renal failure: Plasma creatinine > 0.18 as a result of acute or chronic pathology. Major surgery: Significant surgical procedure resulting in admission to unit or performed on patients already admitted. The majority of these patients were electively admitted for observation following vascular or neurosurgical procedures. Intubation of trachea for ventilatory support.
The maximum therapeutic level reached was considered the outcome variable. Each patient whose requirement exceeds a particular treatment level can be considered as failing to be controlled by a standardised regimen at that level. Thus each patient would be effectively treated by a standardised therapy at or above his or her level and inadequately treated at levels below. This is based on the reasonable assumption that each level provides greater efficacy than the one below.
Analysis of the data was undertaken by calculation of a Pearson correlation matrix, analysis of variance and Chi-squared testing. A P value of < 0.05 was considered significant.
The correlation matrix was calculated to provide information regarding cross relationships between the various risk factors and the outcome variable. Incidence of individual risk factors in study group. Incidence of multiple risk factors in study group. The study complied with our hospital's Ethics Committee guidelines.
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RESULTS
Thirty-three females and sixty-three males were studied. Six patients were aged less than twenty, 37 were between twenty and sixty, 33 between sixty and seventy and 20 older than seventy, No patient suffered clinically overt gastrointestinal bleeding during the study period.
The frequency of risk factors in the group is displayed in Table 1 and the frequency of multiple risk factors in Table 2 . The relationship of the level of therapy to number of risk factors was not statistically significant (P = 0.253).
The correlation matrix for each risk factor, age and therapeutic level is presented as Table 3 . This The individual risk factors that demonstrated a significant relationship to therapeutic level on Chisquared analysis were head injury (P = 0.009), intubation (P = 0.012) and major surgery (P= 0.003).
The percentage of patients that would have had a pH > 4 at each level of therapy is listed in Table 4 for the overall study population and for subgroups with significant risk factors. While head injury and intubation increased the therapy required to control gastric acidity, those electively admitted after major surgery were generally effectively controlled by a lower therapeutic requirement compared with the study sample average. Some form of therapy was required in 85% of cases. Ranitidine alone was effective for all patients with ml2 hourly. All patients studied were controlled by the use of ranitidine 50 mg 8 hourly IV with 60 ml mylanta 2 hourly by nasogastric tube.
DISCUSSION
Patients entering the study demonstrated a wide variety of indications for intensive care admission. They also demonstrated a great variation in their response to therapy limiting gastric acidity.
The study method has provided a means of determining the efficacy of several grades of therapy and helps identify some subgroups where control of gastric pH is more difficult. The use of intravenous ranitidine 50 mg 8 hourly would have been effective in all patients recovering from major surgery without any other risk factors. However, for the rest of the patients only 61 % would have had pH>4.
The subgroup of head-injured patients were even more resistant to therapy with only 47% covered by ranitidine 50 mg IV 8 hourly alone. The particular risks of other subgroups such as sepsis and bums are not well tested by this study because of their small numbers in the sample.
A cost-effectiveness analysis was applied to the data utilising therapy prices from the current MIMS Annual. No allowance was made for the 2 Table 5 . This reveals an overall reduction in cost of medication and increase in effectiveness of control compared with any single level of therapy for all patients. Alternatively, regular ranitidine therapy could be used for elective postoperative admissions and the graded combination regimen for all others. Modification of gastric pH remains a widely accepted therapeutic goal within many intensive care units. This study demonstrates a method of controlling gastric acidity in intensive care patients which is effective in providing appropriate therapy for the wide variety of patients presenting to our Intensive Care Unit. The method ensures most efficient use of resources and provides a model for further investigation. ACKNOWLEDGEMENT We thank FFE Pty Ltd for donation of test strips and Park Davis for donation of Mylanta 11, and Paul Stewart, Craig McNally and the staff of Prince Henry Hospital for their invaluable assistance in undertaking the data collection. Samira Haddad skilfully prepared the manuscript. 
